AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. RPRX
  4. [8-K] Royalty Pharma plc Reports Material Event

[8-K] Royalty Pharma plc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock RPRX logo
Royalty Pharma Plc

NASDAQ:RPRX

RPRX Rankings

#685 Ranked by Market Cap
#1443 Ranked by Dividends

RPRX Latest News

Aug 13, 2025
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors
Aug 6, 2025
Royalty Pharma Reports Second Quarter 2025 Results
Jul 18, 2025
Royalty Pharma Declares Third Quarter 2025 Dividend
Jul 17, 2025
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
Jul 16, 2025
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025

RPRX Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] Royalty Pharma plc SEC Filing
Aug 13, 2025
[8-K] Royalty Pharma plc Reports Material Event
Aug 13, 2025
[SCHEDULE 13G] Royalty Pharma plc SEC Filing
Aug 11, 2025
[Form 4] Royalty Pharma plc Insider Trading Activity
Aug 11, 2025
[144] Royalty Pharma plc SEC Filing

RPRX Stock Data

15.76B
393.15M
8.93%
82.61%
3.97%
Biotechnology
Pharmaceutical Preparations
United States
NEW YORK